Immmunodeficiencies and autoimmune diseases: common variable immunodeficiency and Crohn-like

Area of Science:

• Immunology
• Gastroenterology
• Internal Medicine

Background:

• Common variable immunodeficiency (CVI) is a primary immunodeficiency characterized by impaired antibody production.
• CVI patients face increased risks of infections, autoimmune disorders, and certain cancers.
• Digestive manifestations, including chronic diarrhea, are frequent in CVI, sometimes presenting as the sole clinical feature.

Observation:

• A case of CVI presenting with significant digestive symptoms, initially diagnosed as Crohn-like disease with extensive ileal involvement.
• The patient experienced chronic diarrhea, mimicking inflammatory bowel disease (IBD).
• This presentation highlights the diagnostic challenge in differentiating CVI-related gastrointestinal issues from primary IBD.

Findings:

• Treatment for CVI with severe digestive symptoms follows principles similar to Crohn disease management.
• Immunosuppressive therapy, specifically infliximab, proved effective in achieving clinical remission in a severe case.
• The patient had a prior adverse reaction to adalimumab, underscoring the complexity of biologic selection.

Implications:

• Managing CVI with gastrointestinal involvement requires a careful, individualized approach.
• The use of immunomodulators in CVI presents diagnostic and therapeutic challenges due to the underlying immune dysregulation.
• Further research into optimal treatment strategies for CVI-associated digestive diseases is warranted.